Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer
Clinical trial NCT04068974 · UNKNOWN
Trial details
- NCT number
- NCT04068974
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2021-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.